THE SINGLE BEST STRATEGY TO USE FOR MBL77

Not all individuals with CLL have to have therapy. In spite of all new advances, the iwCLL nevertheless suggests watchful observation for people with asymptomatic illness.86 This suggestion is predicated on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,